In conclusion, we developed a conditionally replicative adenovirus vector, CRAd-synNotch, and a recombinant adenovirus vector, ADX730, containing a synNotch receptor gene that inhibits CD44 signaling and hypoxia-induced response in cancer cells. The gene discussed is CD44; the disease is cancer.